Potential Antiviral Compounds from Hippeastrum puniceum Bulb Against Yellow Fever Virus: Bioassay-Guided Fractionation and In Silico Pharmacokinetic Analysis
Authors:
- Eliza Flores-SouzaEFEliza Flores-Souza
- Alisson Samuel Portes CaldeiraACAlisson Samuel Portes Caldeira
- Carolina Colombelli Pacca-MazaroCPCarolina Colombelli Pacca-Mazaro
- Tamiris Vanessa Miguel de SouzaTSTamiris Vanessa Miguel de Souza
- Thaís Magalhães AcácioThaís Magalhães Acácio
- Emerson de Castro BarbosaEBEmerson de Castro Barbosa
- Naiara Clemente TavaresNTNaiara Clemente Tavares
- Carlos Eduardo Calzavara-SilvaCCCarlos Eduardo Calzavara-Silva
- Carlos Leomar ZaniCZCarlos Leomar Zani
- Douglas Eduardo Valente PiresDPDouglas Eduardo Valente Pires
- Tânia Maria de Almeida AlvesTATânia Maria de Almeida Alves
- Jaquelline Germano de OliveiraJOJaquelline Germano de Oliveira
Open Access
Abstract
Despite the availability of effective vaccines, yellow fever outbreaks persist, highlighting the need for antiviral drugs. Background/Objectives: This study investigated Hippeastrum puniceum (Amaryllidaceae) as a potential source of antiviral compounds against wild-type yellow fever virus (wt-YFV). Methods/Results: The crude bulb extract of H. puniceum exhibited 58% protection against wt-YFV. Bioassay-guided fractionation of the extract by UHPLC-HRMS led to the annotation of six alkaloids (bulbisine, cathinone, trigonelline, tetrahydroharman-3-carboxylic acid, and 2,7-dimethoxyhomolycorine or 3-O-acetylnarcissidine) in active fractions, along with the amino acids arginine, asparagine, tryptophan, and glutamic acid. In silico ADMET analyses predicted favorable pharmacokinetic and toxicological profiles, supporting their potential as drug candidates. Six of the annotated compounds were evaluated in vitro for cytotoxicity and antiviral activity against wt-YFV. However, none showed significant antiviral activity when tested individually, suggesting that the observed antiviral effect may result from synergistic interactions between two or more compounds within active fractions. Conclusions: Our results underscore the importance of further investigations in vitro, particularly assays exploring the synergy among the annotated compounds against YFV. The integration of bioassay-guided fractionation of active plant extracts with computational analyses emerges as a promising strategy for the discovery of natural products with therapeutic potential against yellow fever, a reemerging disease.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais (APQ-00038-22, BPD-00023-22)
- INOVA FIOCRUZ program
This publication has 60 references indexed in Scilit:
- Renaming of the genus Flavivirus to Orthoflavivirus and extension of binomial species names within the family FlaviviridaeArchives of Virology, 2023
- Yellow Fever Reemergence Risk in the Guiana Shield: a Comprehensive Review of Cases Between 1990 and 2022Current Tropical Medicine Reports, 2023
- Alkaloids as potential antivirals. A comprehensive reviewNatural Products and Bioprospecting, 2023
- Structural Diversity and Biological Potential of Alkaloids from the Genus Hippeastrum, Amaryllidaceae: an UpdateRevista Brasileira de Farmacognosia, 2021
- Prediction and Optimization of Pharmacokinetic and Toxicity Properties of the Ligand2018
- MassBank: a public repository for sharing mass spectral data for life sciencesJournal of Mass Spectrometry, 2010
- Amino acids: metabolism, functions, and nutritionAmino Acids, 2009
- Rapid identification of inhibitors that interfere with poliovirus replication using a cell-based assayAntiviral Research, 2008
- Identification of natural compounds with antiviral activities against SARS-associated coronavirusAntiviral Research, 2005
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983